Stem Cell Reports, the official journal of the International Society for Stem Cell Research, has just welcomed Cambridge Stem Cell Institute Director Bertie Göttgens as one of 13 new distinguished researchers to the Editorial Board.
The new appointments are designed to broaden representation across the international landscape of stem cell science and champion the journal, raising its global visibility, and ensuring rigorous, high-quality peer review.
Editor-in-chief Janet Rossant says, “I am delighted to welcome our new editorial board members to Stem Cell Reports. Their breadth of expertise – spanning basic biology, translational research, clinical application, and ethical considerations – reflects the rich diversity of the global stem cell community. Together, we will continue to ensure that the journal serves as a leading platform for high-quality science that informs, inspires, and advances our field.”
The new Stem Cell Reports Editorial Board members include:
Rosario Isasi, University of Miami, USA
Bertie Göttgens, Cambridge Stem Cell Institute, UK
Shimpei Gotoh, Center for iPS Cell Research and Application, Japan
Kristin Hope, University Health Network’s Princess Margaret Cancer Centre, Canada
Darrel Kotton, Boston University Chobanian & Avedisian School of Medicine, USA
Feng Liu, Shandong University/Chinese Academy of Sciences, China
Zubin Master, Wake Forest University, USA
Elizabeth Ng, Murdoch Children’s Research Institute, Australia
Nathan Palpant, The University of Queensland, Australia
Olivier Pourquie, Harvard Medical School/Brigham and Women’s Hospital, USA
Thomas Rando, University of California, Los Angeles, USA
Yonatan Stelzer, Weizmann Institute of Science, Israel
Thor Theunissen, Washington University School of Medicine, USA
The addition of the new board members further strengthens the journal and provides support to the editorial team, which includes five prominent associate editors:
Anne Grapin-Botton, Max Planck Institute of Molecular Cell Biology and Genetics, Germany, investigates how pancreatic cells differentiate and regenerate, with a focus on the influence of tissue architecture on cell fate decisions.
Haruhisa Inoue, Kyoto University, Japan, is a physician-scientist pioneering iPSC-based models and clinical trials for neurodegenerative diseases, including ALS and Alzheimer’s disease.
Martin Pera, The Jackson Laboratory, USA, is a leader in human pluripotent stem cell biology whose research spans self-renewal, pluripotency, and neural differentiation, with applications in disease modeling and regenerative therapies.
April Pyle, University of California, Los Angeles, USA, studies muscle stem cells and human pluripotent stem cell biology to develop regenerative medicine strategies, including CRISPR-based therapies for neuromuscular diseases.
Ludovic Vallier, Berlin Institute of Health, Germany, uses pluripotent stem cells and organoids to study liver development and create cell-based therapies for metabolic and liver diseases.